Articles > Devices & Technology

Better Depression Screening and Higher CGM Adoption: Measuring Data at Diabetes Clinics

At the American Diabetes Association Scientific Sessions, the T1D Exchange Quality Improvement Collaborative shared early findings from efforts to standardize data collection and improve care at pediatric diabetes clinics.

Tidepool Announces Partnership with Medtronic and Dexcom for Tidepool Loop

The goal is to create an interoperable automated insulin delivery device compatible with the Dexcom G6, as well as a future MiniMed pump or future Omnipod pump.

FDA Approves Eversense CGM for Non-Adjunctive Use

Users of the CGM soon will no longer need fingersticks to verify blood glucose readings before making management decisions.

Dual-Hormone iLet Bionic Pancreas Leads to Improvement in Glucose Levels in Small, In-Home Trial

Beta Bionics and Zealand Pharma announce positive Phase 2 results of a small trial of the dual-hormone system ahead of the ADA Scientific Sessions.

T1D Exchange and DreaMed Diabetes Formalize Partnership to Optimize Insulin Treatment Plans in Clinics

Type 1 diabetes decision support technology analyzes patient data from variety of devices to determine insulin delivery recommendations for maintaining balanced glucose levels.

Patch CGM Approved for Use in Europe

Nemaura plans to initially market the SugarBEAT patch CGM, which has predictive glucose alarms, to people with type 2 diabetes.

Medtronic 670G Pump Users Experienced Optimal Blood Sugar Range 71 Percent of the Time

The medtech company unveiled CareLink data showing that the automated basal delivery feature of the pump system helped people with type 1 diabetes experience improved Time in Range.

Pivotal Home Trial of iLet Bionic Pancreas System Announced

The trial is being conducted by Beta Bionics and Zealand Pharma, and marks the first full-scale test of the dual-hormone therapy in a real-world setting.

Senseonics announced a distribution partnership with a verified Service-Disabled Veteran-Owned Small Business to offer the implantable CGM through the Veterans Health Administration.

DIY Automated Insulin Dosing Stakeholders Issue Statement to FDA Warning Against Such Systems

The statement has reportedly been endorsed and co-written by key members of the Loop, OpenAPS, and AndroidAPS movements.